Immuno-Biological Laboratories Co., Ltd. Logo

Immuno-Biological Laboratories Co., Ltd.

Develops and supplies immunological reagents and diagnostics for research and drug discovery.

4570 | T

Overview

Corporate Details

ISIN(s):
JP3921300004
LEI:
Country:
Japan
Address:
藤岡市中字東田1091番地1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Immuno-Biological Laboratories Co., Ltd. (IBL) is a research-driven company that develops, manufactures, and supplies immunological research reagents and diagnostics. The company's portfolio includes ELISA kits, specialized antibodies, and cell culture-related products. IBL focuses on key therapeutic areas such as aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable offering is the LipoSEARCH® lipoprotein analyzing system, which utilizes patented Gel Permeation High-Performance Liquid Chromatography (GP-HPLC) technology. The company collaborates with pharmaceutical partners and research institutions to support drug discovery and the development of novel diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 01:09
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-14 01:07
Interim Report
半期報告書-第44期(2025/04/01-2026/03/31)
Japanese 173.9 KB
2025-06-27 06:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2025-06-27 02:05
Governance Information
内部統制報告書-第43期(2024/04/01-2025/03/31)
Japanese 25.4 KB
2025-06-27 02:04
Registration Form
確認書
Japanese 8.7 KB
2025-06-27 02:02
Annual Report
有価証券報告書-第43期(2024/04/01-2025/03/31)
Japanese 1.2 MB
2024-11-14 01:04
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-14 01:02
Interim Report
半期報告書-第43期(2024/04/01-2025/03/31)
Japanese 180.6 KB
2024-06-26 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2024-06-26 03:41
Governance Information
内部統制報告書-第42期(2023/04/01-2024/03/31)
Japanese 23.7 KB
2024-06-26 03:40
Registration Form
確認書
Japanese 8.7 KB
2024-06-26 03:38
Registration Form
有価証券報告書-第42期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-14 01:10
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-02-14 01:07
Quarterly Report
四半期報告書-第42期第3四半期(2023/10/01-2023/12/31)
Japanese 161.4 KB
2023-11-14 01:02
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Immuno-Biological Laboratories Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Immuno-Biological Laboratories Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Immuno-Biological Laboratories Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America
ADVM
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France
ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden
AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan
2927
AGENUS INC Logo
Develops antibodies, cell therapies & adjuvants to harness the immune system against cancer.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
United States of America
AGIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.